Apitraz 500 Mg Bee-Hive Strips For Honey Bees
Issued: April 2016
AN: 00561/2015 & AN: 01222/2015
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Apitraz 500 mg bee-hive strips for honey bees
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each strip contains:
Amitraz 500 mg
For thefull list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
White rectangular plastic strip with two tabs and a marker fold line.
4. CLINICAL PARTICULARS
4.1 Target species
Honey bees – Apismellifera
4.2 Indications for use,specifying the target species
Treatment of external parasitosis caused by Varroa destructorsensitive to amitraz.
Do not use in the case of known resistance to amitraz.
4.4 Special warnings for each target species
All colonies in the same apiary should be treated simultaneously to avoid robbery.
Do not re-use the strips.
It is recommended not to use the product before the end of the honey producing season of the year.And see section 4.9. Precautions of use and application timetable.
Cases of resistance to amitrazhave been reported in honeybees. In countries with recognized resistance to amitraz the use of the product should ideally be based on results of susceptibility testing. Please, ask your veterinarian for further information.
4.5 Special precautions for use
Special precautions for use in animals
Inappropriate use of the product could result in an increased risk of resistance development and could ultimately result in ineffective therapy.
Bee colonies should be monitored routinely for the level of varroa mite infestation. The product should be used as part of an integrated varroa control programme.
The safety profile for the product has not been established in weak colonies, i.e. those colonies containing a number of bees that is lower than expected for the time of year.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
This veterinary medicinal product contains amitraz, which can lead to neurological side-effects in humans.
Amitraz is a monoamine oxidase inhibitor (MAOI); therefore, people taking MAOI-containing medication should take particular care.
Handleand open container with care to minimise the potential for inhalation.
This veterinary medicinal product may cause skin sensitisation, allergic reactions and eye irritation.
Personal protective equipment consisting of impervious glovesand the usual beekeeping protective clothingshould be worn when handling the veterinary medicinal product.
Avoid contact with skin. In case of contact, wash thoroughly with soap and water.
Avoid contact with eyes. In case of contact, rinse with plenty of water immediately.
If irritation occurs, seek immediate medical advice and show the package leaflet or label to the physician.
Do not eat, drink or smoke during its use.
Keep children well away during application of product.
Wash your hands thoroughly after use.
Do notthrow strips or empty sachets in ponds or streams, as the product could be dangerous for fish and aquatic organisms
4.6 Adverse reactions (frequency and seriousness)
4.7 Use during pregnancy, lactation or lay
4.8 Interaction with other medicinal products and other forms of interaction
The toxicological effect of the amitrazis increased in the presence of copper salts and the therapeutic activity decreases in the presence of piperonylbutoxide. Use of either of these substances with the product should be avoided.
4.9 Amounts to be administered and administration route
Usetwo strips per hive, hang each between two frames ofhoneycomb food stores.
Place the strips between frames where the bees exhibit the greatest mobility. Hang the strips in such a way as to provide bees with free access toboth sides, whilst maintaining bee space.
Hives type Dadant, place one strip between the third and the fourth honeycombs and the other between the seventh and eighth honeycomb.
Hives type Layens, place one strip between the fifth and sixth honeycomb and the other between the ninth and tenth honeycomb.
Strips must be removed after 6 weeks.
The strips should not be cut.
Precautions of use and application timetable:
The product should be used when the amount of brood is low relative to peak levels. In addition, the product should be applied when the bees are still active, i.e. before the bees form a winter cluster, the exact timing of which can vary between climatic zones. Therefore, levels of brood and climatic conditions must be considered prior to product application.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
One and half times the recommended dose, for a period of 8 weeks has been administered and results in a slightly higher number of dead bees compared to the recommended posology.
4.11 Withdrawal period(s)
Honey: zero days
Do not use during honey flow.
Do not harvest honey during the 6 week treatment period
5. PHARMACOLOGICAL PROPERTIES
Pharmacotherapeutic group: Ectoparaciticides, insecticides and repellents
ATCvet code: QP53AD01
5.1 Pharmacodynamic properties
Amitraz is a parasiticide belonging to the formamidine group of insecticides.
Amitrazhas a neurotoxic action. The principal mode of action is interaction with octopamine receptors in the central nervous system (CNS) of ectoparasites which induces increased neuronal activity, abnormal behavior, detachment and death.
5.2 Pharmacokinetic particulars
Contact between the beesandamitraz strip impregnates the varroa outer cuticle and consequently amitraz acts against this mite.
The kinetics of amitraz is unknown in bees.
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Styrene-Butadiene block copolymer
Calcium magnesium carbonate
Ultra-high molecular weight Siloxane polymer, dispersed in polypropylene homopolymer
6.3 Shelf life
Shelf-life of the veterinary medicinal product as packaged for sale: 1 year.
Shelf-life after first opening the immediate packaging: Use immediately.
6.4. Special precautions for storage
Do not store above 25º C.
6.5 Nature and composition of immediate packaging
Sachet containing 10 strips of 300 mm x 40 mm
Sachet containing 10 strips of 250 mm x 48 mm
Not all pack sizes may be marketed.
6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
The veterinary medicinal product should not enter watercourses as this may be dangerous for fish and aquatic organisms.
7. MARKETING AUTHORISATION HOLDER
Laboratorios Calier, S.A.
C/ Barcelonès 26 (Pla del Ramassà)
08520 Les Franqueses del Vallès
8. MARKETING AUTHORISATION NUMBER
9. DATE OF FIRST AUTHORISATION
10 DATE OF REVISION OF THE TEXT
PROHIBITION OF SALE, SUPPLY AND/OR USE